Betaxolol and propranolol in glucagon stimulation of growth hormone. 1984

M Colle, and J Battin, and J P Coquelin, and P Rochiccioli

Both betaxolol and propranolol, beta blockers with different pharmacological properties, increase the reliability of somatotropic testing with glucagon. The combination of glucagon and betaxolol, however, is much better tolerated than that of glucagon and propranolol. The use of a beta 1 cardioselective adrenoceptor block for growth hormone testing is recommended.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D011412 Propanolamines AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives. Aminopropanols
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D006130 Growth Disorders Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth. Stunted Growth,Stunting,Disorder, Growth,Growth Disorder,Growth, Stunted,Stuntings
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Colle, and J Battin, and J P Coquelin, and P Rochiccioli
July 1973, The Journal of clinical endocrinology and metabolism,
M Colle, and J Battin, and J P Coquelin, and P Rochiccioli
April 1981, Medicina clinica,
M Colle, and J Battin, and J P Coquelin, and P Rochiccioli
August 1970, The Journal of clinical endocrinology and metabolism,
M Colle, and J Battin, and J P Coquelin, and P Rochiccioli
September 1971, The Journal of the Medical Society of New Jersey,
M Colle, and J Battin, and J P Coquelin, and P Rochiccioli
September 1975, Acta endocrinologica,
M Colle, and J Battin, and J P Coquelin, and P Rochiccioli
September 1974, Metabolism: clinical and experimental,
M Colle, and J Battin, and J P Coquelin, and P Rochiccioli
September 1975, Metabolism: clinical and experimental,
M Colle, and J Battin, and J P Coquelin, and P Rochiccioli
June 1974, Biomedicine / [publiee pour l'A.A.I.C.I.G.],
M Colle, and J Battin, and J P Coquelin, and P Rochiccioli
April 1971, The Journal of clinical endocrinology and metabolism,
M Colle, and J Battin, and J P Coquelin, and P Rochiccioli
July 1974, Horumon to rinsho. Clinical endocrinology,
Copied contents to your clipboard!